题名 | The relationship between neuromyelitis optica spectrum disorder and autoimmune diseases |
作者 | |
发表日期 | 2024-06-27 |
发表期刊 | FRONTIERS IN IMMUNOLOGY 影响因子和分区 |
语种 | 英语 |
原始文献类型 | Article |
关键词 | Neuromyelitis optica sectrum disorders autoimmune disease annualized relapse rate (ARR) autoimmune antibodies prognosis |
其他关键词 | CLASSIFICATION CRITERIA ; MYASTHENIA-GRAVIS ; DIAGNOSIS ; CONSENSUS |
摘要 | Objective There have been reports of neuromyelitis optica spectrum disorder (NMOSD) coexisting with connective tissue disorders. The objective of this study was to describe the characteristics of NMOSD coexisting with autoimmune diseases (AID).Methods This retrospective study evaluated NMOSD patients with and without AID. The enrolled patients had at least one attack, with duration of more than 1 year. Data on the demographics, clinical features, and laboratory findings were assessed. The Poisson model was used to investigate the risk factors associated with the annualized relapse rate (ARR), whereas the Cox model was used to evaluate the risk factors for the first relapse.Results A total of 180 patients (154 women and 26 men) with NMOSD were identified: 45 had AID and 135 did not. Female patients had a higher prevalence of concomitant AID (p = 0.006) and a greater relapse rate within the first year. There were no statistically significant differences in the characteristics of patients. Kaplan-Meier analysis revealed that NMOSD patients with seropositive aquaporin 4 antibodies (AQP4-Ab; log-rank: p = 0.044), had a shorter time to relapse. Patients seropositive for AQP4-Ab (HR = 2.402, 95%CI = 1.092-5.283, p = 0.029) had a higher risk of suffering a first relapse, according to the Cox model. Patients with and without AID showed a similar declining tendency in terms of change in ARR throughout the first 5 years of the disease. The ARR was greater in the first year [incidence rate ratio (IRR) = 1.534, 95%CI = 1.111-2.118] and the first 2 years (IRR = 1.474, 95%CI = 1.056-2.058) in patients with coexisting AID diagnosis prior to the NMOSD onset.Conclusions Patients with NMOSD with coexisting AID had similar characteristics when compared with those without AID. NMOSD patients with AID diagnosed before onset had a higher risk of relapse in the early stage of the disease. |
资助项目 | Wenzhou Science and Technology Bureau [Y20210168] |
出版者 | FRONTIERS MEDIA SA |
ISSN | 1664-3224 |
卷号 | 15 |
DOI | 10.3389/fimmu.2024.1406409 |
页数 | 8 |
WOS类目 | Immunology |
WOS研究方向 | Immunology |
WOS记录号 | WOS:001268994400001 |
收录类别 | SCIE ; SCOPUS |
URL | 查看原文 |
PubMed ID | 38994358 |
SCOPUSEID | 2-s2.0-85198078741 |
通讯作者地址 | [Li, Xiang;Xia, Junhui]Wenzhou Med Univ, Dept Neurol, Affiliated Hosp 1, Wenzhou, Peoples R China. |
Scopus学科分类 | Immunology and Allergy;Immunology |
引用统计 | |
文献类型 | 期刊论文 |
条目标识符 | https://kms.wmu.edu.cn/handle/3ETUA0LF/216842 |
专题 | 第一临床医学院(信息与工程学院)、附属第一医院_内科学_神经内科 附属第一医院_麻醉科 |
通讯作者 | Li, Xiang; Xia, Junhui |
作者单位 | 1.Wenzhou Med Univ, Dept Neurol, Affiliated Hosp 1, Wenzhou, Peoples R China; 2.Wenzhou Med Univ, Dept Anesthesiol, Affiliated Hosp 1, Wenzhou, Peoples R China |
第一作者单位 | 第一临床医学院(信息与工程学院)、附属第一医院_内科学_神经内科 |
通讯作者单位 | 第一临床医学院(信息与工程学院)、附属第一医院_内科学_神经内科 |
第一作者的第一单位 | 第一临床医学院(信息与工程学院)、附属第一医院_内科学_神经内科 |
推荐引用方式 GB/T 7714 | Lin, Jie,Xue, Binbin,Li, Jia,et al. The relationship between neuromyelitis optica spectrum disorder and autoimmune diseases[J]. FRONTIERS IN IMMUNOLOGY,2024,15. |
APA | Lin, Jie., Xue, Binbin., Li, Jia., Xie, Dewei., Weng, Yiyun., ... & Xia, Junhui. (2024). The relationship between neuromyelitis optica spectrum disorder and autoimmune diseases. FRONTIERS IN IMMUNOLOGY, 15. |
MLA | Lin, Jie,et al."The relationship between neuromyelitis optica spectrum disorder and autoimmune diseases".FRONTIERS IN IMMUNOLOGY 15(2024). |
条目包含的文件 | 条目无相关文件。 |
个性服务 |
查看访问统计 |
谷歌学术 |
谷歌学术中相似的文章 |
[Lin, Jie]的文章 |
[Xue, Binbin]的文章 |
[Li, Jia]的文章 |
百度学术 |
百度学术中相似的文章 |
[Lin, Jie]的文章 |
[Xue, Binbin]的文章 |
[Li, Jia]的文章 |
必应学术 |
必应学术中相似的文章 |
[Lin, Jie]的文章 |
[Xue, Binbin]的文章 |
[Li, Jia]的文章 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论